E. Coli Infection and Drug Resistance Trends in ICU Patients

168.1 KB Excel file contains analysis of Escherichia coli samples from ICU and non-ICU patients. Zeling Dong authored this study to examine infection trends and drug resistance patterns. The dataset was last updated in April 2026.

Use Cases

• Analyze trends in E. coli infection rates over time for ICU versus non-ICU patients.
• Correlate Extended-Spectrum Beta-Lactamase (ESBL) positive rates with overall infection trends.
• Examine multidrug resistance (MDR) rates and their relationship with ICU detection rates.
• Assess drug susceptibility test results for 17 different antibiotics.
• Calculate comprehensive drug resistance rates defined as the ratio of total resistant results to total tests.

Strengths

• Data includes drug susceptibility testing for 17 specific antibiotics.
• Analysis performed using the VITEK-2 Compact system and SPSS 26.0 for statistical correlation.

Limitations

• Dataset size is 168.1 KB, indicating a limited scope and likely small sample size.
• Geographic coverage is restricted to Guizhou, China, limiting generalizability.
• Specific row counts and column names are not provided in the metadata.

Provenance

Source

figshare, authored by Zeling Dong.

Collection Method

Samples collected from outpatients and inpatients; bacterial identification and drug susceptibility testing performed using VITEK-2 Compact system.

Time Range

null

Freshness

Data last updated in April 2026, indicating current relevance.

Geography

Guizhou, China.